SRL Recognition for the FCF


Τhe Flow cytometry Core Facility (FCF) in the LUMC has received an important International recognition as a Shared Resource Laboratory (SRL) by the International Society for the Advancement of Cytometry (ISAC). The recognition was established to recognize SRLs who Uphold a high standard in operations and adherence to best practices and This recognition has only been rewarded to 14 laboratories world-wide. The FCF is a research facility that provides more than 500 researchers and technicians access to state-of-the-art flow cytometers, mass cytometers and cell sorters that are used to analyze and isolate cell populations. In addition, the facility provides trainings for its users and offers advice on experimental design. Since its establishment in 2017 by professors Jacques van Dongen and Frank Staal, the FCF has had a strong focus on quality control and adherence to best practices as outlined by ISAC. Support and guidance by EuroFlow and ESLHO were key in laying a solid foundation for this success. The FCF is very proud of this recognition and will keep improving its’ services and expertise to contribute to the research and diagnostics performed in the LUMC.


  • Sharp rise in venture capital at Leiden Bio Science Park

    Companies at Leiden Bio Science Park attracted around €350 million in venture capital in 2025. That is significantly more than in previous years. This is according to research by real estate advisor CBRE. Venture capital is money invested in new…

  • Permit application submitted for production facility

    On 3 April 2026, RED Company submitted the permit application for the construction of Lilly’s production facility to the Municipality of Katwijk. To demonstrate that the development is feasible and complies with all applicable laws and regulations, RED Company has…

  • Large study reveals hidden potential of cancer drugs

    Patients with advanced cancer for whom standard treatments no longer work may benefit from off-label medicines: approved drugs that are used for a different disease than the one for which they are officially registered. This means a larger group of…